-
-
-
-
-
-
-
Star Therapeutics to present VGA039 trial data at ISTH 2026
-
-
-
-
-
-
-
Incyte (INCY) Reiterated at Market Perform by Citizens Amid Positive Trial Results
-
-
-
-
-
-
-
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance and Highlights 2025 R&D Milestones
-
-
-
-
-
-
-
Incyte Completes Acquisition of Escient Pharmaceuticals
-
-
-
-
-
-
-
Incyte (INCY) PT Lowered to $84 at Oppenheimer
-
1,177,304 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

